The .gov means it's official - federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. It is important for consumers to know that delta-8 products with THC have not been evaluated or approved by the FDA for safe use in any context. They can be marketed in ways that endanger public health and, especially, should be kept out of reach of children and pets.
The FDA is aware of the growing concern surrounding delta-8 products with THC that are currently sold online and in stores. These products have not been evaluated or approved by the FDA for safe use in any context. Some concerns include variability in product formulations and labeling, other cannabinoid and terpene contents, and varying concentrations of THC delta-8.In addition, some of these products may simply be labeled as “hemp products”, which may mislead consumers who associate “hemp” with “non-psychoactive products”. In addition, the FDA is concerned about the proliferation of products containing delta-8 THC and that are marketed for therapeutic or medical uses, even though they have not been approved by the FDA. Selling unapproved products with baseless therapeutic claims is not only a violation of federal law, but it can also put consumers at risk, since these products have not been proven to be safe or effective. This misleading marketing of unproven treatments poses significant public health problems, as patients and other users can use them instead of approved therapies to treat serious and even fatal illnesses.
Delta-8 THC has psychoactive and intoxicating effects, similar to delta-9 THC (i.e. marijuana). The FDA is aware of media reports on products containing THC delta-8 that they “place”.The FDA is also concerned that products with THC delta-8 may expose consumers to much higher levels of the substance than those found naturally in raw hemp and cannabis extracts. Therefore, the historical use of cannabis cannot be relied upon to establish a level of safety for these products in humans.
The FDA is actively working with federal and state partners to further address concerns related to these products and to monitor the market for complaints about products, adverse events, and other emerging cannabis-derived products that may be a cause for concern. The FDA will warn consumers about public health and safety issues and will take action, when necessary, when products regulated by the FDA violate the law. The American Association of Poison Control Centers (AAPCC) maintains the National Poison Data System (NPDS), which contains anonymous case records of self-reported information collected from callers during exposure control and information calls about poisoning administered by the PCC poison control centers). The NPDS data do not reflect the entire universe of exposures to a particular substance, since additional exposures may not be reported to PCC; therefore, the NPDS data should not be interpreted as representing the full incidence of U. S.
exposures. Exposures do not necessarily represent poisoning or overdose, and the AAPCC cannot fully verify the accuracy of each report. The findings based on NPDS data do not necessarily reflect the views of the AAPCC. Sign up for Consumer Update email notifications. A survey of delta-8 users supports this, and respondents reported that they felt less paranoid, less anxious and had a “more pleasant high” compared to delta-9-THC. The most common experiences using delta-8 were relaxation, euphoria, and pain relief.
People reported that they had some difficulty concentrating, short-term memory problems and an altered sense of time, although not to the same extent as with normal marijuana. Delta-8 THC is effective when used as a medication to reduce nausea and vomiting. The scientific role of THC in inhibiting vomiting is not new; scientific evidence has demonstrated for years that delta-9 THC is effective in relieving nausea and reducing or stopping vomiting. The challenge that has prevented the wider use of delta-9 THC to treat these problems comes from its strong psychoactive element. On the other hand, experts say that this could be because there is less of the drug in CB1 receptors so people are less likely to experience more distressing symptoms when they get too high. Delta-8 has become increasingly popular among cannabis users due to its milder psychoactive effects compared to delta-9 THC (i.e., marijuana).
It has been found to provide many of the same benefits as traditional marijuana without some of its more intense side effects such as paranoia or anxiety. Delta-8 has been used for pain relief, relaxation, euphoria, appetite stimulation, nausea reduction, improved sleep quality, improved focus and concentration, improved moods, increased energy levels, improved physical performance, reduced inflammation, improved cognitive function, reduced stress levels, improved immune system functioning. In addition to its therapeutic benefits, delta-8 also offers users a unique experience due to its milder psychoactive effects compared to traditional marijuana. This makes it an attractive option for those who want to experience some of the benefits associated with marijuana without feeling overwhelmed by its more intense effects. Overall, delta-8 offers users a unique experience due to its milder psychoactive effects compared to traditional marijuana while still providing many of its therapeutic benefits. It is important for consumers to understand that delta-8 products with THC have not been evaluated or approved by the FDA for safe use in any context so it is important to research any product before using it.
